2020 GINA Academy Complete Course

Release date: May 7, 2020

Expiration date: May 7, 2021

Estimated time to complete activity: 3.5 hours

Activity Fee: $125 USD



The Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one of the most common chronic lung diseases worldwide contains extensive citations from the scientific literature and forms the basis for other GINA documents and programs. GINA Academy has been designed to provide healthcare providers with critical information to assist with implementation of evidence contained in the GINA strategy document. Certified for continuing education credits for physicians, pharmacists, nurses, respiratory therapists, and other healthcare providers involved in the management of asthma, GINA Academy is a key resource to assist with management of this chronic disease.


GINA Academy activities were developed collaboratively by the Board of Directors, comprised of leading asthma experts. GINA Board of Directors can be found here.


This educational initiative has been designed for physicians, nurse practitioners, physician assistants, respiratory therapists, nurses, pharmacists, and other healthcare providers involved in the management of patients with asthma.


Upon completion of this educational activity, participants should be able to:

  1. Describe the criteria for making the initial diagnosis of asthma
  2. Define criteria for excessive lung function variability
  3. Understand how to confirm the diagnosis of asthma in patients currently taking controller medication
  4. Discuss diagnosis of asthma in specific populations
  5. Describe guideline-recommended strategies for the assessment of asthma control and severity
  6. Categorize asthma symptoms as well controlled, uncontrolled, or poorly controlled
  7. Identify risk factors that may lead to exacerbations of asthma
  8. Classify asthma severity based on retrospective evaluation of therapy and level of control
  9. Name the roles of the main classes of asthma medications
  10. Select appropriate initial treatment for a patient with asthma
  11. Name the components of asthma control and know how to assess them
  12. Adjust asthma treatment appropriately based on an individual’s symptoms and risk profile
  13. Understand how the severity of asthma exacerbations is assessed
  14. Identify patients at increased risk of asthma-related death
  15. Describe the treatment options that can be included in a written asthma action plan
  16. Discuss how to treat a severe exacerbation in a patient presenting to primary care or the emergency department
  17. Distinguish typical asthma from typical COPD and from asthma-COPD overlap
  18. Understand why the labels ‘asthma’ and ‘COPD’ are still important
  19. Select appropriate initial treatment for patients with asthma and/or COPD
  20. Describe the principles of diagnosis, management, monitoring of asthma in primary care
  21. List the education needs of people with asthma in primary care
  22. Describe implementation of good asthma care (both chronic and acute) in primary care practice
  23. Discuss strategies to ensure patient safety in primary care and when to refer patients for specialist assessment and care
  24. Define primary prevention of asthma
  25. Review factors that influence the risk of developing asthma in children
  26. Provide advice to patients and families interested in reducing the risk of their children developing asthma


The fee for participating and receiving credit for this activity is $125 USD. During the period of May 7, 2020 through May 7, 2021, participants must:

  1. Enroll in the course and complete payment of $125 USD
  2. Read the learning objectives and faculty disclosures
  3. Complete the pretest
  4. Study the educational activity
  5. Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Pharmacists must check the CPE monitor for their credits within 60 days of the activity. Pharmacist learners CANNOT claim partial credit for the 2020 GINA Academy Complete Course.




Integrity Continuing Education is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Integrity Continuing Education designates this enduring activity for a maximum of 3.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for a total of 3.50 contact hour(s) (.350 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number – 0530-9999-20-087-H01-P

This is a knowledge-based activity.

Continuing Nursing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 3.50 contact hours is provided by Global Education Group.

Nurses should claim only the credit commensurate with the extent of their participation in the activity.

American Association for Respiratory Care (AARC) Continuing Education

Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.


For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or information@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.


Integrity Continuing Education and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity. Disclosure information for the faculty members can be found here.

The following planners and managers, Patima Tanapat, PhD, Michael Baffuto, Ashley Marostica, RN, MSN, Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. The Global planners and managers have nothing to disclose.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Integrity Continuing Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)


Windows 98, 2000, XP, 2003, Vista, and 7

Internet Explorer 6/7

Firefox 2

Mozilla 1.7 or higher

Netscape 8.1 or higher

Flash Player 10

Mac OS X 10.3, 10.4

Safari 1.3 (Mac OS 10.3)

Safari 2.0 or higher (Mac OS 10.4)

Firefox 2

Flash Player 10

Use of Internet Explorer browser is not recommended.

Click here for more information on minimum system requirements.


The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.



This CME activity is provided by Integrity Continuing Education.

This CE activity is jointly provided by Global Education Group and Integrity Continuing Education.

Get news and updates From

Global Initiative for Asthma in your inbox.